Pharmaceutical importers
Identify import-capable organizations whose licences, product interests and commercial scope align with the opportunity.
International market development
International Pharmaceutical Business Development
KOIT helps pharmaceutical companies and international market partners identify, evaluate and develop cross-border commercial opportunities through market intelligence, partner connections, product sourcing, commercial coordination and market-entry support.
The role in practice
What international pharmaceutical business development means
International pharmaceutical business development starts with a specific commercial question: which market has a relevant need, which product and supply capability fit it, and which organizations are positioned to evaluate the opportunity?
KOIT studies buyer and market requirements, connects suitable manufacturers with potential partners, develops importer and distributor relationships, and supports focused commercial discussions. The work continues by coordinating the product, documentation, supply and market-entry inputs needed to move a qualified opportunity toward a potential transaction.
KOIT acts as the market-connection and coordination partner. It does not manufacture products, grant approvals, provide legal or tax advice, or guarantee sales, registration or market entry.
Market and partner development
The right relationship depends on the specific opportunity
A credible partner match must reflect the product, target market, regulatory pathway, channel, commercial expectations and each party’s ability to perform its role.
Distributors and commercial partners
Develop conversations with partners whose channels, geographic reach and portfolio strategy fit the proposed products.
Institutional and procurement partners
Assess supply opportunities involving hospitals, procurement organizations and other institutional channels where requirements are clearly defined.
Local pharmaceutical companies
Connect with companies seeking supply, licensing, manufacturing or portfolio-development relationships in their markets.
Manufacturers and product owners
Match relevant capabilities and portfolios with suitable international demand, documentation needs and commercial structures.
Market-entry partners
Coordinate with local regulatory, commercial and operational parties needed to evaluate a responsible route to market.
Market-specific development
Market access begins with local commercial reality
KOIT evaluates opportunities across Latin America, Southeast Asia, Africa, CIS and other emerging markets. Every market is assessed independently; regional interest does not imply a guaranteed opportunity, approval or available route to market.
- Product demand and portfolio fit
- Existing market and channel structure
- Import and distribution requirements
- Applicable regulatory environment
- Commercial viability and supply considerations
- Local partner capabilities and responsibilities
- Procurement and institutional opportunities
Manufacturer and product sourcing
Translating buyer requirements into viable supply options
Business development may begin with an international buyer’s need for a particular molecule, dosage form, specification, pack, documentation profile or volume. KOIT identifies suitable pharmaceutical manufacturers and products, then coordinates the initial capability, document and commercial review.
Manufacturer suitability depends on the actual requirement. Product availability or a GMP credential alone does not establish destination-market approval or buyer acceptance.
Explore pharmaceutical sourcing from IndiaDistributor and importer development
Developing relevant market relationships
KOIT helps pharmaceutical companies engage potential importers, distributors, commercial partners and institutional supply partners whose scope may fit the proposed portfolio. Engagement includes opportunity framing, introductory discussions, requirement exchange and next-step coordination.
KOIT does not guarantee distributor appointment, sales performance or market entry. Each organization conducts its own review, due diligence and decision process.
Commercial coordination
Keeping product, partner and supply discussions aligned
- 1Product, dosage-form and market requirements
- 2Commercial discussions and responsibility mapping
- 3Pricing, volumes, terms and supply considerations
- 4Product, quality and manufacturer documentation
- 5Manufacturer, buyer and local-partner coordination
- 6Clear next steps toward a potential transaction
Regulatory and market-entry coordination
Commercial progress must align with market requirements
A commercially relevant product still needs an appropriate import, registration, distribution and supply pathway. KOIT coordinates information and responsibilities among manufacturers, importers, distributors and specialist regulatory parties so the commercial discussion reflects the destination market’s requirements.
KOIT does not issue approvals or guarantee registration. The responsible authority and qualified local parties determine the applicable pathway and outcome.
Explore product registration coordinationBusiness models
Support shaped around the commercial structure
International pharmaceutical opportunities can require different supply, manufacturing and market-entry structures. KOIT helps the parties assess and coordinate the model that fits the requirement.
Merchant Export
Coordinate products sourced from suitable Indian manufacturers for export to international buyers.
ExploreContract Manufacturing
Develop buyer-specific pharmaceutical manufacturing programs based on product, volume, documentation and market needs.
ExploreNeutral-Code Manufacturing
Coordinate discreet, buyer-specific manufacturing and packaging structures with confidentiality and compliance requirements in view.
ExploreMerchant Trade Transactions
Assess cross-border supply structures in which goods move between two overseas jurisdictions under an appropriately coordinated transaction.
ExploreProduct Registration Coordination
Align manufacturers, importers, distributors and specialist regulatory parties around destination-market documentation and submission requirements.
ExploreSpecial Purpose Import
Evaluate specific institutional, medical or program-led import requirements under the applicable destination-market pathway.
ExploreProcess
From a defined opportunity to coordinated next steps
- 01
Opportunity Assessment
Define the product, market, commercial objective, target partner and initial feasibility considerations.
- 02
Market and Partner Mapping
Identify relevant markets and suitable counterparties based on the opportunity’s commercial and regulatory profile.
- 03
Engagement and Qualification
Open structured discussions and assess mutual interest, capability, documentation and decision readiness.
- 04
Commercial and Regulatory Alignment
Coordinate product, pricing, supply, documentation and market-entry requirements with the responsible parties.
- 05
Transaction Development
Support agreed next steps toward a potential supply, manufacturing, registration or market-entry arrangement.
FAQ
Questions about international pharmaceutical business development
What is international pharmaceutical business development?+
It is the structured work of identifying suitable markets, products and partners, developing qualified commercial relationships, and coordinating the requirements that may lead to an international pharmaceutical transaction or long-term market presence.
Who does KOIT work with?+
KOIT works with pharmaceutical manufacturers, product owners, importers, distributors, institutional buyers, procurement partners, local pharmaceutical companies and market-entry partners. Suitability is assessed for each specific product, market and commercial objective.
Can KOIT identify pharmaceutical distributors or importers?+
KOIT can identify and engage potential distributors, importers and commercial partners whose capabilities appear relevant to the requirement. Any appointment, agreement or transaction remains subject to qualification, due diligence, mutual acceptance and applicable market requirements.
Does KOIT guarantee sales, distributor appointments or market entry?+
No. KOIT develops and coordinates qualified opportunities but does not guarantee sales, partner appointments, registrations, approvals or market entry. Outcomes depend on product fit, partner decisions, commercial terms and the applicable regulatory process.
Can business development include manufacturer and product sourcing?+
Yes. Where a buyer has a defined requirement, KOIT can identify suitable pharmaceutical manufacturers and products, assess initial capability and documentation, and coordinate commercial discussions. Final supplier approval remains with the relevant buyer and responsible parties.
Does KOIT handle pharmaceutical registration?+
KOIT coordinates registration-related requirements with manufacturers, importers, distributors and specialist regulatory parties. KOIT is not a regulator, does not issue approvals and does not guarantee registration in any market.
Develop an international opportunity
Discuss your market, product or partnership objective with KOIT.
Share the target market, product portfolio, partner requirement and commercial context. KOIT will assess the appropriate business-development path.